Mymetics Corporation
OTC: MYMX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ronald Kempers
- Employees
- 2
- Headquarters
- Epalinges, Switzerland
- IPO year
- 1999
- Market cap
- $46.0
- Website
- https://www.mymetics.com
Loading MYMX…
Loading profile data…Frequently asked questions about MYMX
What does Mymetics Corporation (MYMX) do?
Mymetics Corporation is a Swiss biotechnology company dedicated to the research and development of vaccines aimed at preventing infectious and debilitating diseases. Its robust pipeline features several promising vaccine candidates, including those for HIV-1/AIDS, COVID-19, intranasal influenza, respiratory syncytial virus (RSV), malaria, and ch...
Where does MYMX trade?
Mymetics Corporation (MYMX) trades on the Other OTC.
What sector is MYMX in?
Mymetics Corporation (MYMX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Mymetics Corporation?
Ronald Kempers is the chief executive officer of Mymetics Corporation (MYMX).
Where is Mymetics Corporation headquartered?
Mymetics Corporation is headquartered in Switzerland.
Does MYMX pay a dividend?
Mymetics Corporation (MYMX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MYMX go public?
Mymetics Corporation (MYMX) completed its initial public offering in 1999.